Exosome blood test for predicting ovarian cancer recurrence
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study is testing whether a blood test based on tiny particles called exosomes can help predict if ovarian cancer will come back. It may help doctors plan better follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 18 years old.
- You have been diagnosed with epithelial ovarian cancer (stage I to IV).
- Your overall health is reasonably good (ECOG score 0–2).
- You were diagnosed within the last 8 weeks.
- You have not received any cancer treatment for ovarian cancer yet.
- You have not had both ovaries removed before.
- You are not pregnant and have not had cancer in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test can predict the risk of ovarian cancer coming back after treatment. It might help doctors decide who needs more aggressive therapy.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
This trial tests a new blood test (OCS) that may help detect if ovarian cancer comes back after initial treatment. It is for people whose CA125 levels were normal at diagnosis.
This study uses a simple blood test to look for tiny bits of cancer DNA after your treatment. It aims to see if this test can help predict whether the cancer might come back.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.